- Home
- ANIX vs EPM Comparison
ANIX vs EPM Comparison
Compare ANIX & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANIX | EPM |
|---|---|---|
| Founded | 1982 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 124.2M |
| IPO Year | 1987 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ANIX | EPM |
|---|---|---|
| Price | $2.99 | $4.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $9.00 | $4.93 |
| AVG Volume (30 Days) | 244.6K | ★ 356.6K |
| Earning Date | 03-10-2026 | 02-10-2026 |
| Dividend Yield | N/A | ★ 12.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $85,232,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.33 | $3.19 |
| 52 Week High | $5.46 | $5.70 |
Technical Indicators
Market Signals| Indicator | ANIX | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 34.76 | 62.76 |
| Support Level | $2.75 | $3.87 |
| Resistance Level | $3.09 | $4.13 |
| Average True Range (ATR) | 0.15 | 0.11 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 5.00 | 76.20 |
Price Performance
Historical ComparisonAbout ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.